Immunohistochemical localization of the cloned κ1 receptor in the rat CNS and pituitary
References (68)
- et al.
Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord
Brain Res.
(1990) - et al.
Technical aspects of opioid receptor localization: detection of opioid receptor proteins by immunocytochemistry or with a biotinylated dynorphin analog
J. Neurosci. Meth.
(1994) - et al.
Moloclonal anti-idiotypic antibodies to opioid receptors
J. biol. Chem.
(1988) - et al.
Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase
Analyt. Biochem.
(1991) - et al.
Effect of y and x opioid receptor agonists on rat plasma corticosterone levels
Eur. J. Pharmac.
(1985) - et al.
Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa
Brain Res.
(1986) - et al.
Effect of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes
Life Sci.
(1986) - et al.
μ, δ- and κ-opioid receptor modulation of the hypothalamic-pituitaryadrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides
Brain Res.
(1987) - et al.
Activation of κ-opioid receptors inhibits depolarisation-evoked exocytosis but not the rise in intracellular Ca2+ in secretory nerve terminals of the neurohypophysis
Brain Res.
(1992) - et al.
Immunocytochemical visualization of kappa-opioid receptors on chick embryonic neurons differentiating in vitro
Neuroscience
(1993)
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Trends Neurosci.
Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS
J. Chem. Neuroanat.
κ1 Receptor mRNA distribution in the rat CNS: comparison to κ receptor binding and prodynorphin mRNA
Molec. Cell. Neurosci.
Anatomy of CNS opioid receptors
Trends Neurosci.
Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist norbinaltorphimine
Life Sci.
κ-Opioid receptors and analgesia
Trends pharmac. Sci.
In situ hybridization study of κ-opioid receptor mRNA in the rat brain
Neurosci. Lett.
[3HIU-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3Hlethylketocyclazoeine
Life Sci.
Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus
Eur. J. Pharmac.
Immunohistochemical localization of κ opioid receptors in the human frontal cortex
Brain Res.
Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors
Peptides
The anticonvulsant action of CI-977, a selective κ-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex
Eur. J. Pharmac.
Single-step purification of polypeptides expressed in Eschericha coli as fusions with glutathione S-transferase
Gene
Cloning and pharmacological characterization of a rat μ opioid receptor
Neuron
The kappa-opioid receptor: evidence for the different subtypes
Life Sci.
Multiple opiate receptors: support for unique mu, delta and kappa sites
Neuropharmacology
Functional κ-opioid receptors on oxytocin and vasopressin nerve terminals isolated from the rat neurohypophysis
Brain Res.
δ-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin
J. Neurosci.
Distribution and targeting of a μ-opioid receptor (MORI) in brain and spinal cord
J. Neurosci.
Characterization of opioid binding sites in the rat pituitary gland by quantitative receptor autoradiography
J. Neuroendocr.
Selective cardiovascular and neuroendocrine effects of a κ-opioid agonist in the nucleus tractus solitarii of rats
J. Physiol.
High efficiency transformation of mammalian cells by plasmid DNA
Molec. Cell Biol.
Moloclonal antiidiotypic antibodies against delta opioid receptors as an electron microscopy probe
Eur. J. Cell Biol.
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats
J. Pharmac. exp. Ther.
Cited by (133)
Pain-related cortico-limbic plasticity and opioid signaling
2023, NeuropharmacologyKappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors
2021, NeuropharmacologyCitation Excerpt :Neuroplasticity in BLA and CeA has been linked to pain-like behaviors in different pain conditions (Allen et al., 2020; Corder et al., 2019; Neugebauer, 2020; Neugebauer et al., 2004; Thompson and Neugebauer, 2019; Wilson et al., 2019). The amygdala is one of the brain areas with particularly high expression of KOR based on radioligand binding, immunohistochemistry and in situ hybridization (Cahill et al., 2014; Le Merrer et al., 2009; Mansour et al., 1995, 1996). Dynorphin, considered the endogenous ligand for KOR (Bruchas et al., 2010), is synthesized primarily in neurons in the lateral CeA (CeL) (Marchant et al., 2007), and one third of these neurons co-express corticotropin-releasing factor (Marchant et al., 2007).
Structure and function of the medial amygdala
2020, Handbook of Behavioral NeuroscienceThe amygdalar opioid system
2020, Handbook of Behavioral NeuroscienceKappa opioid receptors mediate yohimbine-induced increases in impulsivity in the 5-choice serial reaction time task
2019, Behavioural Brain ResearchCitation Excerpt :Although the brain regions responsible for either of these effects are not clear, a potential candidate for the pro-impulsive effects of yohimbine is the orbitofrontal cortex (OFC). The OFC contains DYN and KOR [60–62] and it plays a key role in yohimbine-induced increases in impulsivity in the 5-CSRTT [23]. A potential alternative explanation of increased premature responding produced by yohimbine and nicotine is that rats use a timing strategy to guide when they make their responses [63] and that drug-induced increases in premature responses reflect disruption of this strategy.